| UniProt ID | TFE2_HUMAN | |
|---|---|---|
| UniProt AC | P15923 | |
| Protein Name | Transcription factor E2-alpha | |
| Gene Name | TCF3 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 654 | |
| Subcellular Localization | Nucleus. | |
| Protein Description | Transcriptional regulator. Involved in the initiation of neuronal differentiation. Heterodimers between TCF3 and tissue-specific basic helix-loop-helix (bHLH) proteins play major roles in determining tissue-specific cell fate during embryogenesis, like muscle or early B-cell differentiation. Dimers bind DNA on E-box motifs: 5'-CANNTG-3'. Binds to the kappa-E2 site in the kappa immunoglobulin gene enhancer. Binds to IEB1 and IEB2, which are short DNA sequences in the insulin gene transcription control region.. | |
| Protein Sequence | MNQPQRMAPVGTDKELSDLLDFSMMFPLPVTNGKGRPASLAGAQFGGSGLEDRPSSGSWGSGDQSSSSFDPSRTFSEGTHFTESHSSLSSSTFLGPGLGGKSGERGAYASFGRDAGVGGLTQAGFLSGELALNSPGPLSPSGMKGTSQYYPSYSGSSRRRAADGSLDTQPKKVRKVPPGLPSSVYPPSSGEDYGRDATAYPSAKTPSSTYPAPFYVADGSLHPSAELWSPPGQAGFGPMLGGGSSPLPLPPGSGPVGSSGSSSTFGGLHQHERMGYQLHGAEVNGGLPSASSFSSAPGATYGGVSSHTPPVSGADSLLGSRGTTAGSSGDALGKALASIYSPDHSSNNFSSSPSTPVGSPQGLAGTSQWPRAGAPGALSPSYDGGLHGLQSKIEDHLDEAIHVLRSHAVGTAGDMHTLLPGHGALASGFTGPMSLGGRHAGLVGGSHPEDGLAGSTSLMHNHAALPSQPGTLPDLSRPPDSYSGLGRAGATAAASEIKREEKEDEENTSAADHSEEEKKELKAPRARTSPDEDEDDLLPPEQKAEREKERRVANNARERLRVRDINEAFKELGRMCQLHLNSEKPQTKLLILHQAVSVILNLEQQVRERNLNPKAACLKRREEEKVSGVVGDPQMVLSAPHPGLSEAHNPAGHM | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 12 | Phosphorylation | QRMAPVGTDKELSDL CCCCCCCCCHHHHHH | 44.10 | 23403867 | |
| 23 | Phosphorylation | LSDLLDFSMMFPLPV HHHHCCHHHCCCCCC | 14.70 | 22210691 | |
| 34 | Acetylation | PLPVTNGKGRPASLA CCCCCCCCCCCHHHC | 54.54 | 22207202 | |
| 39 | Phosphorylation | NGKGRPASLAGAQFG CCCCCCHHHCCCCCC | 22.80 | 25159151 | |
| 39 (in isoform 3) | Phosphorylation | - | 22.80 | 29507054 | |
| 48 (in isoform 3) | Phosphorylation | - | 40.35 | 25627689 | |
| 51 (in isoform 3) | Phosphorylation | - | 56.34 | 29507054 | |
| 55 | Phosphorylation | SGLEDRPSSGSWGSG CCCCCCCCCCCCCCC | 48.50 | 23401153 | |
| 57 (in isoform 3) | Phosphorylation | - | 31.58 | 25159151 | |
| 102 | Phosphorylation | GPGLGGKSGERGAYA CCCCCCCCCCCCCCC | 49.51 | 29449344 | |
| 105 | Methylation | LGGKSGERGAYASFG CCCCCCCCCCCCCCC | 38.27 | - | |
| 108 | Phosphorylation | KSGERGAYASFGRDA CCCCCCCCCCCCCCC | 12.95 | 28796482 | |
| 110 | Phosphorylation | GERGAYASFGRDAGV CCCCCCCCCCCCCCC | 18.63 | 28555341 | |
| 121 | Phosphorylation | DAGVGGLTQAGFLSG CCCCCCCHHHCHHCC | 21.46 | 28464451 | |
| 127 | Phosphorylation | LTQAGFLSGELALNS CHHHCHHCCEEECCC | 28.14 | 23403867 | |
| 134 | Phosphorylation | SGELALNSPGPLSPS CCEEECCCCCCCCCC | 31.89 | 26055452 | |
| 139 | Phosphorylation | LNSPGPLSPSGMKGT CCCCCCCCCCCCCCC | 21.83 | 30278072 | |
| 141 | Phosphorylation | SPGPLSPSGMKGTSQ CCCCCCCCCCCCCCC | 48.41 | 30278072 | |
| 146 | Phosphorylation | SPSGMKGTSQYYPSY CCCCCCCCCCCCCCC | 13.72 | 21945579 | |
| 147 | Phosphorylation | PSGMKGTSQYYPSYS CCCCCCCCCCCCCCC | 25.50 | 21945579 | |
| 149 | Phosphorylation | GMKGTSQYYPSYSGS CCCCCCCCCCCCCCC | 19.67 | 21945579 | |
| 150 | Phosphorylation | MKGTSQYYPSYSGSS CCCCCCCCCCCCCCC | 4.32 | 21945579 | |
| 152 | Phosphorylation | GTSQYYPSYSGSSRR CCCCCCCCCCCCCCC | 18.79 | 21945579 | |
| 153 | Phosphorylation | TSQYYPSYSGSSRRR CCCCCCCCCCCCCCC | 16.73 | 26074081 | |
| 154 | Phosphorylation | SQYYPSYSGSSRRRA CCCCCCCCCCCCCCC | 36.21 | 21945579 | |
| 156 | Phosphorylation | YYPSYSGSSRRRAAD CCCCCCCCCCCCCCC | 18.09 | 25262027 | |
| 157 | Phosphorylation | YPSYSGSSRRRAADG CCCCCCCCCCCCCCC | 33.07 | 21945579 | |
| 165 | Phosphorylation | RRRAADGSLDTQPKK CCCCCCCCCCCCCCC | 24.50 | 26074081 | |
| 168 | Phosphorylation | AADGSLDTQPKKVRK CCCCCCCCCCCCCCC | 52.65 | 27794612 | |
| 171 | Acetylation | GSLDTQPKKVRKVPP CCCCCCCCCCCCCCC | 54.83 | 30588339 | |
| 182 | Phosphorylation | KVPPGLPSSVYPPSS CCCCCCCCCCCCCCC | 37.16 | 26552605 | |
| 183 | Phosphorylation | VPPGLPSSVYPPSSG CCCCCCCCCCCCCCC | 24.59 | 26552605 | |
| 185 | Phosphorylation | PGLPSSVYPPSSGED CCCCCCCCCCCCCCC | 16.04 | 26552605 | |
| 188 | Phosphorylation | PSSVYPPSSGEDYGR CCCCCCCCCCCCCCC | 46.61 | 25159151 | |
| 189 | Phosphorylation | SSVYPPSSGEDYGRD CCCCCCCCCCCCCCC | 52.56 | 28985074 | |
| 193 | Phosphorylation | PPSSGEDYGRDATAY CCCCCCCCCCCCCCC | 15.12 | 26552605 | |
| 198 | Phosphorylation | EDYGRDATAYPSAKT CCCCCCCCCCCCCCC | 30.89 | 26074081 | |
| 200 | Phosphorylation | YGRDATAYPSAKTPS CCCCCCCCCCCCCCC | 8.05 | 26074081 | |
| 202 | Phosphorylation | RDATAYPSAKTPSST CCCCCCCCCCCCCCC | 29.71 | 26074081 | |
| 205 | Phosphorylation | TAYPSAKTPSSTYPA CCCCCCCCCCCCCCC | 28.28 | 26074081 | |
| 207 | Phosphorylation | YPSAKTPSSTYPAPF CCCCCCCCCCCCCCE | 40.31 | 26074081 | |
| 208 | Phosphorylation | PSAKTPSSTYPAPFY CCCCCCCCCCCCCEE | 32.91 | 26074081 | |
| 209 | Phosphorylation | SAKTPSSTYPAPFYV CCCCCCCCCCCCEEE | 37.55 | 26074081 | |
| 210 | Phosphorylation | AKTPSSTYPAPFYVA CCCCCCCCCCCEEEE | 10.19 | 26074081 | |
| 229 | Phosphorylation | HPSAELWSPPGQAGF CCCCHHCCCCCCCCC | 33.56 | 26074081 | |
| 244 | Phosphorylation | GPMLGGGSSPLPLPP CCCCCCCCCCCCCCC | 31.86 | 26074081 | |
| 245 | Phosphorylation | PMLGGGSSPLPLPPG CCCCCCCCCCCCCCC | 33.46 | 28464451 | |
| 253 | Phosphorylation | PLPLPPGSGPVGSSG CCCCCCCCCCCCCCC | 45.77 | 26074081 | |
| 292 | Phosphorylation | GGLPSASSFSSAPGA CCCCCHHHHCCCCCC | 28.94 | 20068231 | |
| 294 | Phosphorylation | LPSASSFSSAPGATY CCCHHHHCCCCCCCC | 27.77 | 23898821 | |
| 295 | Phosphorylation | PSASSFSSAPGATYG CCHHHHCCCCCCCCC | 36.15 | 23898821 | |
| 300 | Phosphorylation | FSSAPGATYGGVSSH HCCCCCCCCCCCCCC | 28.72 | 20068231 | |
| 301 | Phosphorylation | SSAPGATYGGVSSHT CCCCCCCCCCCCCCC | 16.02 | 23898821 | |
| 305 | Phosphorylation | GATYGGVSSHTPPVS CCCCCCCCCCCCCCC | 21.48 | 26074081 | |
| 306 | Phosphorylation | ATYGGVSSHTPPVSG CCCCCCCCCCCCCCC | 29.04 | 20068231 | |
| 308 | O-linked_Glycosylation | YGGVSSHTPPVSGAD CCCCCCCCCCCCCCC | 31.10 | OGP | |
| 308 | Phosphorylation | YGGVSSHTPPVSGAD CCCCCCCCCCCCCCC | 31.10 | 20068231 | |
| 312 | Phosphorylation | SSHTPPVSGADSLLG CCCCCCCCCCCCCCC | 33.75 | 23898821 | |
| 316 | Phosphorylation | PPVSGADSLLGSRGT CCCCCCCCCCCCCCC | 25.59 | 23898821 | |
| 320 | Phosphorylation | GADSLLGSRGTTAGS CCCCCCCCCCCCCCC | 27.75 | 23898821 | |
| 327 | Phosphorylation | SRGTTAGSSGDALGK CCCCCCCCCHHHHHH | 28.78 | 28634120 | |
| 328 | Phosphorylation | RGTTAGSSGDALGKA CCCCCCCCHHHHHHH | 39.51 | 21815630 | |
| 334 | Acetylation | SSGDALGKALASIYS CCHHHHHHHHHHHHC | 40.87 | 22207202 | |
| 338 | Phosphorylation | ALGKALASIYSPDHS HHHHHHHHHHCCCCC | 23.94 | 28464451 | |
| 340 | Phosphorylation | GKALASIYSPDHSSN HHHHHHHHCCCCCCC | 16.20 | 30576142 | |
| 341 | Phosphorylation | KALASIYSPDHSSNN HHHHHHHCCCCCCCC | 23.37 | 23927012 | |
| 345 | Phosphorylation | SIYSPDHSSNNFSSS HHHCCCCCCCCCCCC | 41.99 | 28464451 | |
| 346 | Phosphorylation | IYSPDHSSNNFSSSP HHCCCCCCCCCCCCC | 32.16 | 28464451 | |
| 350 | Phosphorylation | DHSSNNFSSSPSTPV CCCCCCCCCCCCCCC | 31.84 | 23927012 | |
| 351 | Phosphorylation | HSSNNFSSSPSTPVG CCCCCCCCCCCCCCC | 41.97 | 23927012 | |
| 352 | Phosphorylation | SSNNFSSSPSTPVGS CCCCCCCCCCCCCCC | 22.98 | 23927012 | |
| 354 | Phosphorylation | NNFSSSPSTPVGSPQ CCCCCCCCCCCCCCC | 47.49 | 23927012 | |
| 355 | Phosphorylation | NFSSSPSTPVGSPQG CCCCCCCCCCCCCCC | 25.94 | 23927012 | |
| 359 | Phosphorylation | SPSTPVGSPQGLAGT CCCCCCCCCCCCCCC | 17.81 | 23927012 | |
| 366 | Phosphorylation | SPQGLAGTSQWPRAG CCCCCCCCCCCCCCC | 16.49 | 28450419 | |
| 367 | Phosphorylation | PQGLAGTSQWPRAGA CCCCCCCCCCCCCCC | 29.36 | 28450419 | |
| 371 | Methylation | AGTSQWPRAGAPGAL CCCCCCCCCCCCCCC | 42.57 | - | |
| 379 | Phosphorylation | AGAPGALSPSYDGGL CCCCCCCCCCCCCCC | 15.97 | 22167270 | |
| 379 (in isoform 2) | Phosphorylation | - | 15.97 | 18669648 | |
| 381 | Phosphorylation | APGALSPSYDGGLHG CCCCCCCCCCCCCCH | 32.26 | 22167270 | |
| 381 (in isoform 2) | Phosphorylation | - | 32.26 | 18669648 | |
| 382 | Phosphorylation | PGALSPSYDGGLHGL CCCCCCCCCCCCCHH | 23.22 | 23927012 | |
| 382 (in isoform 2) | Phosphorylation | - | 23.22 | 18669648 | |
| 391 | Phosphorylation | GGLHGLQSKIEDHLD CCCCHHHHHHHHHHH | 40.41 | 23927012 | |
| 392 | Sumoylation | GLHGLQSKIEDHLDE CCCHHHHHHHHHHHH | 36.83 | - | |
| 411 | Phosphorylation | LRSHAVGTAGDMHTL HHHCCCCCCCCHHHC | 22.37 | - | |
| 434 | Phosphorylation | SGFTGPMSLGGRHAG CCCCCCCCCCCCCCC | 27.31 | 28555341 | |
| 463 (in isoform 3) | Phosphorylation | - | 18.93 | 25159151 | |
| 491 | Phosphorylation | GLGRAGATAAASEIK CCCHHHHHHHHHHHH | 18.86 | 27174698 | |
| 495 | Phosphorylation | AGATAAASEIKREEK HHHHHHHHHHHHHHH | 34.82 | 27174698 | |
| 498 | Sumoylation | TAAASEIKREEKEDE HHHHHHHHHHHHHCC | 50.10 | - | |
| 498 | Sumoylation | TAAASEIKREEKEDE HHHHHHHHHHHHHCC | 50.10 | 28112733 | |
| 502 | Sumoylation | SEIKREEKEDEENTS HHHHHHHHHCCCCCC | 66.76 | - | |
| 508 | Phosphorylation | EKEDEENTSAADHSE HHHCCCCCCCCCCCH | 24.03 | 29978859 | |
| 509 | Phosphorylation | KEDEENTSAADHSEE HHCCCCCCCCCCCHH | 32.80 | 29255136 | |
| 514 | Phosphorylation | NTSAADHSEEEKKEL CCCCCCCCHHHHHHH | 47.45 | 23401153 | |
| 528 | Phosphorylation | LKAPRARTSPDEDED HHCCCCCCCCCCCCC | 43.56 | 30576142 | |
| 528 (in isoform 2) | Phosphorylation | - | 43.56 | 27273156 | |
| 529 | Phosphorylation | KAPRARTSPDEDEDD HCCCCCCCCCCCCCC | 25.46 | 25218447 | |
| 529 (in isoform 2) | Phosphorylation | - | 25.46 | 23927012 | |
| 530 (in isoform 2) | Phosphorylation | - | 48.69 | 23927012 | |
| 531 (in isoform 2) | Phosphorylation | - | 75.61 | 27273156 | |
| 536 (in isoform 2) | Phosphorylation | - | 48.32 | 30108239 | |
| 570 | Ubiquitination | RDINEAFKELGRMCQ HHHHHHHHHHHHHHH | 60.11 | - | |
| 579 (in isoform 2) | Phosphorylation | - | 9.33 | - | |
| 584 | Ubiquitination | QLHLNSEKPQTKLLI HHHCCCCCCCCEEHH | 42.10 | - | |
| 614 | Ubiquitination | RERNLNPKAACLKRR HHCCCCHHHHHHHHH | 47.76 | - | |
| 625 | Sumoylation | LKRREEEKVSGVVGD HHHHHHHHHCCCCCC | 45.01 | 28112733 | |
| 625 | Ubiquitination | LKRREEEKVSGVVGD HHHHHHHHHCCCCCC | 45.01 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 39 | S | Phosphorylation | Kinase | PAK5 | Q9P286 | PSP |
| 48 | S | Phosphorylation | Kinase | CDK2 | P24941 | GPS |
| 48 | S | Phosphorylation | Kinase | CDK4 | P11802 | GPS |
| 139 | S | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
| 139 | S | Phosphorylation | Kinase | CDK4 | P11802 | PSP |
| 154 | S | Phosphorylation | Kinase | CDK2 | P24941 | GPS |
| 154 | S | Phosphorylation | Kinase | CDK4 | P11802 | GPS |
| 245 | S | Phosphorylation | Kinase | CDK4 | P11802 | PSP |
| 245 | S | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
| 341 | S | Phosphorylation | Kinase | MAP3K10 | Q02779 | GPS |
| 352 | S | Phosphorylation | Kinase | MAP3K10 | Q02779 | GPS |
| 352 | S | Phosphorylation | Kinase | MAPK1 | P28482 | GPS |
| 355 | T | Phosphorylation | Kinase | MAP3K10 | Q02779 | GPS |
| 355 | T | Phosphorylation | Kinase | MAPK1 | P28482 | GPS |
| 355 | T | Phosphorylation | Kinase | MAPK-FAMILY | - | GPS |
| 355 | T | Phosphorylation | Kinase | MAPK_GROUP | - | PhosphoELM |
| 359 | S | Phosphorylation | Kinase | MAPK1 | P28482 | GPS |
| 359 | S | Phosphorylation | Kinase | MAP3K10 | Q02779 | GPS |
| 379 | S | Phosphorylation | Kinase | MAP3K10 | Q02779 | GPS |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TFE2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TFE2_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-139 AND SER-359, ANDMASS SPECTROMETRY. | |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-379, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-379, PHOSPHORYLATION[LARGE SCALE ANALYSIS] AT THR-531 (ISOFORM 2), AND MASS SPECTROMETRY. | |